bioRxiv Science⌕ Search

Biology subjects

Voda, A.-I.

Publications and source records attributed to Voda, A.-I..

4 recordsLinked to original sources

Novel joint enrichment test demonstrates high performance in simulations and identifies cell-types with enriched expression of inflammatory bowel disease risk loci

A number of methods have been developed to assess the enrichment of polygenic risk variants - from summary statistics of genome-wide association studies (GWAS) - within specific gene-sets, pathways, or cell-type signatures. The assumptions made by these methods vary, which leads to differences in results and performance across different genetic trait architectures and sample sizes. We devise a novel statistical test that combines independent signals from each of three commonly-used enrichment tests (LDSC, MAGMA & SNPsea) into a single P-value, called the block jackknife GWAS joint enrichment test (GWASJET). Through simulations, we show that this method has comparable or greater power than competing methods across a range of sample sizes and trait architectures. We use our new test in an extensive analysis of the cell-type specific enrichment of genetic risk for inflammatory bowel disease (IBD), including Crohns disease (CD) and ulcerative colitis (UC). Counterintuitively, we find stronger enrichments of IBD risk genes in older gene expression data from bulk immune cell-types than in single-cell data from inflamed patient intestinal samples. We demonstrate that GWASJET removes many seemingly-spurious enriched cell-types identified by other methods, and identifies a core set of immune cells that express IBD risk genes, particularly myeloid cells that have been experimentally stimulated. We also demonstrate that many cell-types are differentially enriched for CD compared to UC risk genes, for example gamma-delta T cells show stronger enrichment for CD than UC risk genes. Author summaryGenetic association studies have discovered a number of DNA variations that are associated with heritable human diseases and traits. One method of investigating the functions of these variants is to test whether they are enriched in parts of the genome associated with specific cell-types or cell conditions - defined by gene expression data or other similar data types. However, there are a number of published statistical methods to test such enrichments; these methdos make different assumptions and their results can vary, sometimes dramatically. We present a novel consensus method, called GWASJET, that combines the results of these different methods to produce a single result. We show that GWASJET can outperform individual methods in simulations. We apply this method to gene expression data from a number of tissues and conditions relevant to inflammatory bowel diseases (IBD). Our method removes potentially false results based on a priori biological knowledge, and reveals that IBD genes are generally clustered in a large number of immune cell-types, especially myeloid cells treated with specific stimulatory molecules.

genetics↗

A longitudinal single-cell therapeutic atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease

Precision medicine in immune-mediated inflammatory diseases (IMIDs) requires an understanding of how cellular networks change following therapy. We describe a therapeutic atlas for Crohns disease (CD) and ulcerative colitis (UC) following anti-tumour necrosis factor (TNF) therapy. We generated ~1 million single-cell transcriptomes, organised into 109 cell states, from 216 gut biopsies from 38 patients and three controls, revealing disease- and therapy-specific differences. A systems-biology analysis identified distinct spatially-resolved cellular microenvironments: granuloma signatures in CD and interferon (IFN)-response signatures localising to T-cell aggregates and epithelial damage in CD and UC. Longitudinal comparisons demonstrated that disease progression in non-responders associated with myeloid and stromal cell perturbations in CD and increased multi-cellular IFN signalling in UC. IFN signalling was also observed in rheumatoid arthritis (RA) synovium with a lymphoid pathotype. Our therapeutic atlas informs drug positioning across IMIDs, and suggests a rationale for the use of janus kinase (JAK) inhibition following anti-TNF resistance.

immunology↗

Alternative paths to immune activation: the role of costimulatory risk genes for polygenic inflammatory disease in T helper cells

T cell activation pathways have been repeatedly implicated by genetic studies as being enriched for risk genes for immune and inflammatory diseases. Many of these risk genes code for costimulatory receptors or ligands. Costimulatory receptors are cell surface proteins on T cells, which are engaged by costimulatory ligands on antigen-presenting cells. Both costimulation and antigen binding are required to trigger T cell activation. In order to study the different pathways activated by these costimulatory risk molecules, and the role they may play in inflammatory disease genetics, we carried out gene expression (RNA-seq) and chromatin accessibility (ATAC-seq) profiling of naive and memory CD4+ T cells (N=5 donors) activated via four different costimulatory receptors: CD28 (the standard molecule used for in vitro activation studies), along with alternative costimulatory molecules ICOS, CD6, and CD27. Most, but not all, activation genes and regions are shared by different costimulation conditions. Alternative costimulation induced lower proliferation and cytokine production, but higher lysosome production, altered metabolic processing, and indications of "signal seeking" behaviour (homing and expression of costimulatory and cytokine receptors). We validated a number of these functions at the surface protein level using orthogonal experimental techniques. We found the strongest enrichment of heritability for inflammatory bowel disease in shared regions upregulated by all costimulatory molecules. However, some risk variants and genes were only induced by alternative costimulation, and the impact of these variants on expression were less often successfully mapped in studies of T cells activated by traditional CD28 costimulation. This suggests that future genetics studies of gene expression in activated T cells may benefit from including alternative costimulation conditions.

genomics↗

Global accumulation of circRNAs during aging in Caenorhabditis elegans

Circular RNAs (CircRNAs) are a newly appreciated class of RNAs that lack free 5{acute} and 3{acute} ends, are expressed by the thousands in diverse forms of life, and are mostly of enigmatic function. Ostensibly due to their resistance to exonucleases, circRNAs are known to be exceptionally stable. Here, we examined the global profile of circRNAs in C. elegans during aging by performing ribo-depleted total RNA-seq from the fourth larval stage (L4) through 10-day old adults. Using stringent bioinformatic criteria and experimental validation, we annotated 1,166 circRNAs, including 575 newly discovered circRNAs. These circRNAs were derived from 797 genes with diverse functions, including genes involved in the determination of lifespan. A massive accumulation of circRNAs during aging was uncovered. Many hundreds of circRNAs were significantly increased among the aging time-points and increases of select circRNAs by over 40-fold during aging were quantified by qRT-PCR. The age-accumulation of circRNAs was not accompanied by increased expression of linear RNAs from the same host genes. We attribute the global scale of circRNA age-accumulation to the high composition of postmitotic cells in adult C. elegans, coupled with the high resistance of circRNAs to decay. These findings suggest that the exceptional stability of circRNAs might explain age-accumulation trends observed from neural tissues of other organisms, which also have a high composition of post-mitotic cells. Given the suitability of C. elegans for aging research, it is now poised as an excellent model system to determine if there are functional consequences of circRNA accumulation during aging.

genomics↗